Biological characterization of PM226, a chromenoisoxazole, as a selective CB 2 receptor agonist with neuroprotective profile

Saved in:
Bibliographic Details
Published inPharmacological research Vol. 110; pp. 205 - 215
Main Authors Gómez-Cañas, M., Morales, P., García-Toscano, L., Navarrete, C., Muñoz, E., Jagerovic, N., Fernández-Ruiz, J., García-Arencibia, M., Pazos, M.R.
Format Journal Article
LanguageEnglish
Published 01.08.2016
Online AccessGet full text

Cover

Author Fernández-Ruiz, J.
García-Toscano, L.
Navarrete, C.
Muñoz, E.
García-Arencibia, M.
Morales, P.
Gómez-Cañas, M.
Pazos, M.R.
Jagerovic, N.
Author_xml – sequence: 1
  givenname: M.
  surname: Gómez-Cañas
  fullname: Gómez-Cañas, M.
– sequence: 2
  givenname: P.
  surname: Morales
  fullname: Morales, P.
– sequence: 3
  givenname: L.
  surname: García-Toscano
  fullname: García-Toscano, L.
– sequence: 4
  givenname: C.
  surname: Navarrete
  fullname: Navarrete, C.
– sequence: 5
  givenname: E.
  surname: Muñoz
  fullname: Muñoz, E.
– sequence: 6
  givenname: N.
  surname: Jagerovic
  fullname: Jagerovic, N.
– sequence: 7
  givenname: J.
  surname: Fernández-Ruiz
  fullname: Fernández-Ruiz, J.
– sequence: 8
  givenname: M.
  surname: García-Arencibia
  fullname: García-Arencibia, M.
– sequence: 9
  givenname: M.R.
  surname: Pazos
  fullname: Pazos, M.R.
BookMark eNotkMtuwjAURL2gUoH2B7ryBzSpHyHEy4L6kqjaBXvLj2swCnFkpy_Uj6-jsprRzNWV5szQpAsdIHRDSUkJre8OZb-PqWTZl4SXhNEJmlJS8aKuaXOJZikdCCGiomSKflc-tGHnjWqx2auozADRn9TgQ4eDw--vjNW3WOUyhiN0wafwrU6hhRymnCdowQz-E_B6hRmOYKAfQsRqFzqfBvzlhz3u4COGPobhfJqt8y1coQun2gTXZ52j7ePDdv1cbN6eXtb3m8IIRotlZYFXUGmnlQbjmKgFMdYtG-vyYKb0QtiGuYWoHbOaMsuZXlrdcCqUdQ2fI_b_1sSQUgQn--iPKv5ISuSITB7kiEyOyCThMiPjfxGRZ5c
CitedBy_id crossref_primary_10_3389_fnins_2016_00406
crossref_primary_10_1186_s12974_018_1060_5
crossref_primary_10_2174_0929867329666220825161603
crossref_primary_10_1007_s12035_019_1495_4
crossref_primary_10_1016_j_jddst_2017_04_023
crossref_primary_10_1016_j_phrs_2017_04_002
crossref_primary_10_1016_j_phrs_2021_105492
crossref_primary_10_3390_ijms21145064
crossref_primary_10_1002_adsc_202100448
crossref_primary_10_1016_j_pbb_2021_173119
crossref_primary_10_3390_ijms24032348
crossref_primary_10_1016_j_phrs_2017_02_019
crossref_primary_10_3390_biomedicines11061546
crossref_primary_10_1002_adsc_202300680
crossref_primary_10_1016_j_ejphar_2021_173875
crossref_primary_10_1021_acs_orglett_9b00097
crossref_primary_10_1016_j_ejphar_2021_174398
crossref_primary_10_1111_bph_15155
crossref_primary_10_1016_j_ejmech_2024_116298
crossref_primary_10_1016_j_phrs_2021_105607
crossref_primary_10_3389_fnmol_2023_1061220
crossref_primary_10_3389_fphar_2019_01284
crossref_primary_10_1021_acs_jmedchem_6b00397
Cites_doi 10.1016/S0169-409X(00)00129-0
10.1186/1471-2377-6-12
10.1002/cmdc.201100568
10.1038/sj.bjp.0705662
10.1111/j.1476-5381.2011.01278.x
10.1021/acs.jmedchem.5b00078
10.2174/1389557054368844
10.2174/156802610791164193
10.1111/j.1476-5381.2009.00625.x
10.1111/j.1460-9568.2009.06764.x
10.1021/cn200114w
10.1124/jpet.107.125955
10.1007/s11481-015-9602-4
10.1007/s13311-015-0381-7
10.1124/mol.65.4.999
10.1111/bph.12283
10.1074/jbc.M205797200
10.1093/brain/awp239
10.1021/jm4005626
10.1016/j.ejmech.2015.06.057
10.1073/pnas.96.25.14228
10.2174/0929867321666140915141332
10.1111/j.1476-5381.2012.02042.x
10.1111/j.1476-5381.2010.00729.x
10.2174/1874467207666140219122337
10.1007/s11481-009-9147-5
10.1523/JNEUROSCI.22-22-09742.2002
10.1517/14728210902736568
10.1371/journal.pone.0138986
10.1523/JNEUROSCI.23-16-06470.2003
10.1016/j.pnpbp.2015.03.017
10.1016/j.neuropharm.2012.05.034
10.1046/j.1471-4159.1999.721759.x
10.1038/sj.bjp.0707527
10.1126/science.1115740
10.1111/j.1476-5381.2011.01414.x
10.1523/JNEUROSCI.23-35-11136.2003
10.1017/S1462399409000957
10.1016/j.neulet.2010.03.026
10.1016/j.plipres.2013.05.004
10.1016/j.brainresrev.2008.12.003
10.3233/JAD-130137
10.1111/j.1476-5381.2010.00819.x
10.1177/0269881110367732
10.1038/cddis.2013.387
10.1016/j.tips.2006.11.001
10.1002/glia.21061
10.1016/j.neuroscience.2015.10.041
10.1002/glia.20983
10.1007/978-3-319-20825-1_1
10.1523/JNEUROSCI.23-04-01398.2003
10.1002/glia.20838
10.1369/0022155414530995
ContentType Journal Article
DBID AAYXX
CITATION
DOI 10.1016/j.phrs.2016.03.021
DatabaseName CrossRef
DatabaseTitle CrossRef
DeliveryMethod fulltext_linktorsrc
Discipline Pharmacy, Therapeutics, & Pharmacology
EndPage 215
ExternalDocumentID 10_1016_j_phrs_2016_03_021
GroupedDBID ---
--K
--M
.GJ
.~1
0R~
0SF
0ZK
123
1B1
1RT
1~.
1~5
29O
3O-
4.4
457
4G.
53G
5RE
5VS
7-5
71M
8P~
9JM
AACTN
AAEDT
AAEDW
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AAQXK
AAXKI
AAXUO
AAYXX
ABFNM
ABFRF
ABJNI
ABMAC
ABOCM
ABXDB
ABZDS
ACDAQ
ACGFO
ACGFS
ACRLP
ADBBV
ADEZE
ADFGL
ADMUD
ADVLN
AEBSH
AEFWE
AEKER
AENEX
AFJKZ
AFKWA
AFTJW
AFXIZ
AGHFR
AGUBO
AGYEJ
AHHHB
AIEXJ
AIKHN
AITUG
AJOXV
AKRWK
ALCLG
ALMA_UNASSIGNED_HOLDINGS
AMFUW
AMRAJ
ASPBG
AVWKF
AXJTR
AZFZN
BKOJK
BLXMC
C45
CAG
CITATION
COF
CS3
DM4
DU5
EBS
EFBJH
EJD
EO8
EO9
EP2
EP3
F5P
FDB
FEDTE
FGOYB
FIRID
FNPLU
FYGXN
G-2
G-Q
GBLVA
GROUPED_DOAJ
HMT
HVGLF
HX~
HZ~
IHE
J1W
KOM
L7B
LG5
M33
M41
MO0
N9A
O-L
O9-
OAUVE
OGGZJ
OVD
OZT
P-8
P-9
P2P
PC.
Q38
R2-
RIG
ROL
RPZ
SCC
SDF
SDG
SDP
SES
SEW
SPCBC
SPT
SSP
SSZ
T5K
TEORI
UNMZH
WUQ
XPP
ZU3
ZXP
~G-
ID FETCH-LOGICAL-c921-74de34e4bfbabecf29690cdf78df1012ab59d82f596f2db12d32b7db8319adf83
ISSN 1043-6618
IngestDate Thu Sep 26 19:28:20 EDT 2024
IsPeerReviewed true
IsScholarly true
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c921-74de34e4bfbabecf29690cdf78df1012ab59d82f596f2db12d32b7db8319adf83
PageCount 11
ParticipantIDs crossref_primary_10_1016_j_phrs_2016_03_021
PublicationCentury 2000
PublicationDate 2016-08-00
PublicationDateYYYYMMDD 2016-08-01
PublicationDate_xml – month: 08
  year: 2016
  text: 2016-08-00
PublicationDecade 2010
PublicationTitle Pharmacological research
PublicationYear 2016
References Van Sickle (10.1016/j.phrs.2016.03.021_bib0270) 2005; 310
Palazuelos (10.1016/j.phrs.2016.03.021_bib0190) 2009; 132
Carrier (10.1016/j.phrs.2016.03.021_bib0045) 2004; 65
Li (10.1016/j.phrs.2016.03.021_bib0140) 2015; 311
Lanciego (10.1016/j.phrs.2016.03.021_bib0130) 2011; 25
10.1016/j.phrs.2016.03.021_bib0180
Schmöle (10.1016/j.phrs.2016.03.021_bib0230) 2015; 10
Ragusa (10.1016/j.phrs.2016.03.021_bib0215) 2015; 101
Gómez Del Pulgar (10.1016/j.phrs.2016.03.021_bib0095) 2002; 277
Sheng (10.1016/j.phrs.2016.03.021_bib0235) 2009; 4
Valdeolivas (10.1016/j.phrs.2016.03.021_bib0260) 2012; 3
Molina-Holgado (10.1016/j.phrs.2016.03.021_bib0170) 2003; 23
García (10.1016/j.phrs.2016.03.021_bib0075) 2011; 163
Rodríguez-Cueto (10.1016/j.phrs.2016.03.021_bib0220) 2014; 171
Blázquez (10.1016/j.phrs.2016.03.021_bib0025) 1999; 72
Steffens (10.1016/j.phrs.2016.03.021_bib0245) 2012; 167
Atwood (10.1016/j.phrs.2016.03.021_bib0015) 2010; 160
Cabral (10.1016/j.phrs.2016.03.021_bib0035) 2009; 11
Smith (10.1016/j.phrs.2016.03.021_bib0240) 2000; 293
Marchalant (10.1016/j.phrs.2016.03.021_bib0160) 2014; 62
Lin (10.1016/j.phrs.2016.03.021_bib0145) 2007; 323
Galve-Roperh (10.1016/j.phrs.2016.03.021_bib0070) 2013; 52
Molina-Holgado (10.1016/j.phrs.2016.03.021_bib0165) 2002; 22
Yiangou (10.1016/j.phrs.2016.03.021_bib0280) 2006; 6
Pazos (10.1016/j.phrs.2016.03.021_bib0200) 2012; 63
Leleu-Chavain (10.1016/j.phrs.2016.03.021_bib0135) 2013; 6
Price (10.1016/j.phrs.2016.03.021_bib0210) 2009; 29
Carbone (10.1016/j.phrs.2016.03.021_bib0040) 2014; 21
Fernández-Ruiz (10.1016/j.phrs.2016.03.021_bib0065) 2015; 12
Espejo-Porras (10.1016/j.phrs.2016.03.021_bib0055) 2015; 10
Walter (10.1016/j.phrs.2016.03.021_bib0275) 2003; 23
Lunn (10.1016/j.phrs.2016.03.021_bib0155) 2010; 10
Gómez-Gálvez (10.1016/j.phrs.2016.03.021_bib0100) 2016; 64
Paxinos (10.1016/j.phrs.2016.03.021_bib0195) 1997
Anand (10.1016/j.phrs.2016.03.021_bib0005) 2009; 60
Janero (10.1016/j.phrs.2016.03.021_bib0125) 2009; 14
Pertwee (10.1016/j.phrs.2016.03.021_bib0205) 2015; 231
Han (10.1016/j.phrs.2016.03.021_bib0105) 2013; 56
Oh (10.1016/j.phrs.2016.03.021_bib0185) 2010; 474
Henstridge (10.1016/j.phrs.2016.03.021_bib0115) 2010; 160
Sagredo (10.1016/j.phrs.2016.03.021_bib0225) 2009; 57
Lipinski (10.1016/j.phrs.2016.03.021_bib0150) 2001; 46
Gómez (10.1016/j.phrs.2016.03.021_bib0085) 2010; 58
Cumella (10.1016/j.phrs.2016.03.021_bib0050) 2012; 7
Gómez (10.1016/j.phrs.2016.03.021_bib0090) 2011; 163
Buckley (10.1016/j.phrs.2016.03.021_bib0030) 2008; 153
Benito (10.1016/j.phrs.2016.03.021_bib0020) 2003; 23
Aso (10.1016/j.phrs.2016.03.021_bib0010) 2013; 35
Hanus (10.1016/j.phrs.2016.03.021_bib0110) 1999; 96
Valdeolivas (10.1016/j.phrs.2016.03.021_bib0265) 2013; 4
Huffman (10.1016/j.phrs.2016.03.021_bib0120) 2005; 5
Morales (10.1016/j.phrs.2016.03.021_bib0175) 2015; 58
Toulmond (10.1016/j.phrs.2016.03.021_bib0255) 2004; 141
García-Gutiérrez (10.1016/j.phrs.2016.03.021_bib0080) 2010; 160
Fernández-Ruiz (10.1016/j.phrs.2016.03.021_bib0060) 2007; 28
Stella (10.1016/j.phrs.2016.03.021_bib0250) 2010; 58
References_xml – volume: 46
  start-page: 3
  year: 2001
  ident: 10.1016/j.phrs.2016.03.021_bib0150
  article-title: computational approaches to estimate solubility and permeability in drug discovery and development settings
  publication-title: Adv. Drug Delivery Rev.
  doi: 10.1016/S0169-409X(00)00129-0
  contributor:
    fullname: Lipinski
– volume: 6
  start-page: 12
  year: 2006
  ident: 10.1016/j.phrs.2016.03.021_bib0280
  article-title: COX-2, CB2 and P2×7-immunoreactivities are increased in activated microglial cells/macrophages of multiple sclerosis and amyotrophic lateral sclerosis spinal cord
  publication-title: BMC Neurol.
  doi: 10.1186/1471-2377-6-12
  contributor:
    fullname: Yiangou
– volume: 7
  start-page: 452
  year: 2012
  ident: 10.1016/j.phrs.2016.03.021_bib0050
  article-title: Chromenopyrazoles: non-psychoactive and selective CB cannabinoid agonists with peripheral antinociceptive properties
  publication-title: ChemMedChem
  doi: 10.1002/cmdc.201100568
  contributor:
    fullname: Cumella
– volume: 141
  start-page: 689
  year: 2004
  ident: 10.1016/j.phrs.2016.03.021_bib0255
  article-title: Neuroprotective effects of M826, a reversible caspase-3 inhibitor, in the rat malonate model of Huntington's disease
  publication-title: Br. J. Pharmacol.
  doi: 10.1038/sj.bjp.0705662
  contributor:
    fullname: Toulmond
– volume: 163
  start-page: 1495
  year: 2011
  ident: 10.1016/j.phrs.2016.03.021_bib0075
  article-title: Symptom-relieving and neuroprotective effects of the phytocannabinoid (Δ9-THCV in animal models of Parkinson’s disease
  publication-title: Br. J. Pharmacol.
  doi: 10.1111/j.1476-5381.2011.01278.x
  contributor:
    fullname: García
– volume: 58
  start-page: 2256
  year: 2015
  ident: 10.1016/j.phrs.2016.03.021_bib0175
  article-title: Selective, nontoxic CB2 cannabinoid o-quinone with in vivo activity against triple-negative breast cancer
  publication-title: J. Med. Chem.
  doi: 10.1021/acs.jmedchem.5b00078
  contributor:
    fullname: Morales
– volume: 5
  start-page: 641
  year: 2005
  ident: 10.1016/j.phrs.2016.03.021_bib0120
  article-title: CB2 receptor ligands
  publication-title: Mini Rev. Med. Chem.
  doi: 10.2174/1389557054368844
  contributor:
    fullname: Huffman
– volume: 10
  start-page: 768
  year: 2010
  ident: 10.1016/j.phrs.2016.03.021_bib0155
  article-title: Updating the chemistry and biology of cannabinoid CB2 receptor-specific inverse agonists
  publication-title: Curr. Top. Med. Chem.
  doi: 10.2174/156802610791164193
  contributor:
    fullname: Lunn
– ident: 10.1016/j.phrs.2016.03.021_bib0180
– volume: 160
  start-page: 604
  year: 2010
  ident: 10.1016/j.phrs.2016.03.021_bib0115
  article-title: GPR55 ligands promote receptor coupling to multiple signalling pathways
  publication-title: Br. J. Pharmacol.
  doi: 10.1111/j.1476-5381.2009.00625.x
  contributor:
    fullname: Henstridge
– volume: 29
  start-page: 2177
  year: 2009
  ident: 10.1016/j.phrs.2016.03.021_bib0210
  article-title: WIN55,212-2, a cannabinoid receptor agonist, protects against nigrostriatal cell loss in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease
  publication-title: Eur. J. Neurosci.
  doi: 10.1111/j.1460-9568.2009.06764.x
  contributor:
    fullname: Price
– volume: 3
  start-page: 400
  year: 2012
  ident: 10.1016/j.phrs.2016.03.021_bib0260
  article-title: Sativex-like combination of phytocannabinoids is neuroprotective in malonate-lesioned rats, an inflammatory model of Huntington's disease: role of CB1 and CB2 receptors
  publication-title: ACS Chem. Neurosci.
  doi: 10.1021/cn200114w
  contributor:
    fullname: Valdeolivas
– volume: 323
  start-page: 877
  year: 2007
  ident: 10.1016/j.phrs.2016.03.021_bib0145
  article-title: Neuroprotective effects of glyceryl nonivamide against microglia-like cells and 6-hydroxydopamine-induced neurotoxicity in SH-SY5Y human dopaminergic neuroblastoma cells
  publication-title: J. Pharmacol. Exp. Ther.
  doi: 10.1124/jpet.107.125955
  contributor:
    fullname: Lin
– volume: 10
  start-page: 233
  year: 2015
  ident: 10.1016/j.phrs.2016.03.021_bib0055
  article-title: Changes in the endocannabinoid signaling system in CNS structures of TDP-43 transgenic mice: relevance for a neuroprotective therapy in TDP-43-related disorders
  publication-title: J. Neuroimmune Pharmacol.
  doi: 10.1007/s11481-015-9602-4
  contributor:
    fullname: Espejo-Porras
– volume: 12
  start-page: 793
  year: 2015
  ident: 10.1016/j.phrs.2016.03.021_bib0065
  article-title: Cannabinoids in neurodegenerative disorders and stroke/brain trauma: from preclinical models to clinical applications
  publication-title: Neurotherapeutics
  doi: 10.1007/s13311-015-0381-7
  contributor:
    fullname: Fernández-Ruiz
– volume: 65
  start-page: 999
  year: 2004
  ident: 10.1016/j.phrs.2016.03.021_bib0045
  article-title: Cultured rat microglial cells synthesize the endocannabinoid 2-arachidonylglycerol, which increases proliferation via a CB2 receptor-dependent mechanism
  publication-title: Mol. Pharmacol.
  doi: 10.1124/mol.65.4.999
  contributor:
    fullname: Carrier
– volume: 171
  start-page: 1472
  year: 2014
  ident: 10.1016/j.phrs.2016.03.021_bib0220
  article-title: Changes in CB1 and CB2 receptors in the post-mortem cerebellum of humans affected by spinocerebellar ataxias
  publication-title: Br. J. Pharmacol.
  doi: 10.1111/bph.12283
  contributor:
    fullname: Rodríguez-Cueto
– volume: 277
  start-page: 36527
  year: 2002
  ident: 10.1016/j.phrs.2016.03.021_bib0095
  article-title: Cannabinoids protect astrocytes from ceramide-induced apoptosis through the phosphatidylinositol 3-kinase/protein kinase B pathway
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.M205797200
  contributor:
    fullname: Gómez Del Pulgar
– volume: 132
  start-page: 3152
  year: 2009
  ident: 10.1016/j.phrs.2016.03.021_bib0190
  article-title: Microglial CB2 cannabinoid receptors are neuroprotective in Huntington's disease excitotoxicity
  publication-title: Brain
  doi: 10.1093/brain/awp239
  contributor:
    fullname: Palazuelos
– volume: 56
  start-page: 8224
  year: 2013
  ident: 10.1016/j.phrs.2016.03.021_bib0105
  article-title: Therapeutic utility of cannabinoid receptor type 2 (CB2) selective agonists
  publication-title: J. Med. Chem.
  doi: 10.1021/jm4005626
  contributor:
    fullname: Han
– volume: 101
  start-page: 651
  year: 2015
  ident: 10.1016/j.phrs.2016.03.021_bib0215
  article-title: Synthesis, pharmacological evaluation and docking studies of pyrrole structure-based CB2 receptor antagonists
  publication-title: Eur. J. Med. Chem.
  doi: 10.1016/j.ejmech.2015.06.057
  contributor:
    fullname: Ragusa
– volume: 96
  start-page: 14228
  year: 1999
  ident: 10.1016/j.phrs.2016.03.021_bib0110
  article-title: HU-308: a specific agonist for CB2, a peripheral cannabinoid receptor
  publication-title: Proc. Natl. Acad. Sci. U.S.A.
  doi: 10.1073/pnas.96.25.14228
  contributor:
    fullname: Hanus
– volume: 21
  start-page: 4046
  year: 2014
  ident: 10.1016/j.phrs.2016.03.021_bib0040
  article-title: Cannabinoid receptor type 2 activation in atherosclerosis and acute cardiovascular diseases
  publication-title: Curr. Med. Chem.
  doi: 10.2174/0929867321666140915141332
  contributor:
    fullname: Carbone
– volume: 167
  start-page: 313
  year: 2012
  ident: 10.1016/j.phrs.2016.03.021_bib0245
  article-title: Targeting cannabinoid receptor CB2 in cardiovascular disorders: promises and controversies
  publication-title: Br. J. Pharmacol.
  doi: 10.1111/j.1476-5381.2012.02042.x
  contributor:
    fullname: Steffens
– volume: 160
  start-page: 467
  year: 2010
  ident: 10.1016/j.phrs.2016.03.021_bib0015
  article-title: CB2: a cannabinoid receptor with an identity crisis
  publication-title: Br. J. Pharmacol.
  doi: 10.1111/j.1476-5381.2010.00729.x
  contributor:
    fullname: Atwood
– volume: 6
  start-page: 183
  year: 2013
  ident: 10.1016/j.phrs.2016.03.021_bib0135
  article-title: Therapeutical potential of CB receptors in immune-related diseases
  publication-title: Curr. Mol. Pharmacol.
  doi: 10.2174/1874467207666140219122337
  contributor:
    fullname: Leleu-Chavain
– volume: 4
  start-page: 244
  year: 2009
  ident: 10.1016/j.phrs.2016.03.021_bib0235
  article-title: WIN55,212-2 inhibits production of CX3CL1 by human astrocytes: involvement of p38 MAP kinase
  publication-title: J. Neuroimmune Pharmacol.
  doi: 10.1007/s11481-009-9147-5
  contributor:
    fullname: Sheng
– volume: 22
  start-page: 9742
  year: 2002
  ident: 10.1016/j.phrs.2016.03.021_bib0165
  article-title: Cannabinoids promote oligodendrocyte progenitor survival: involvement of cannabinoid receptors and phosphatidylinositol-3 kinase/Akt signaling
  publication-title: J. Neurosci.
  doi: 10.1523/JNEUROSCI.22-22-09742.2002
  contributor:
    fullname: Molina-Holgado
– volume: 14
  start-page: 43
  year: 2009
  ident: 10.1016/j.phrs.2016.03.021_bib0125
  article-title: Cannabinoid receptor antagonists: pharmacological opportunities, clinical experience, and translational prognosis
  publication-title: Expert Opin. Emerg. Drugs
  doi: 10.1517/14728210902736568
  contributor:
    fullname: Janero
– volume: 10
  start-page: e0138986
  year: 2015
  ident: 10.1016/j.phrs.2016.03.021_bib0230
  article-title: Expression analysis of CB2-GFP BAC transgenic mice
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0138986
  contributor:
    fullname: Schmöle
– volume: 23
  start-page: 6470
  year: 2003
  ident: 10.1016/j.phrs.2016.03.021_bib0170
  article-title: Endogenous interleukin-1 receptor antagonist mediates anti-inflammatory and neuroprotective actions of cannabinoids in neurons and glia
  publication-title: J. Neurosci.
  doi: 10.1523/JNEUROSCI.23-16-06470.2003
  contributor:
    fullname: Molina-Holgado
– volume: 64
  start-page: 200
  year: 2016
  ident: 10.1016/j.phrs.2016.03.021_bib0100
  article-title: Potential of the cannabinoid CB2 receptor as a pharmacological target against inflammation in Parkinson's disease
  publication-title: Prog. Neuropsychopharmacol. Biol. Psychiatry
  doi: 10.1016/j.pnpbp.2015.03.017
  contributor:
    fullname: Gómez-Gálvez
– volume: 63
  start-page: 776
  year: 2012
  ident: 10.1016/j.phrs.2016.03.021_bib0200
  article-title: Cannabidiol administration after hypoxia-ischemia to newborn rats reduces long-term brain injury and restores neurobehavioral function
  publication-title: Neuropharmacology
  doi: 10.1016/j.neuropharm.2012.05.034
  contributor:
    fullname: Pazos
– year: 1997
  ident: 10.1016/j.phrs.2016.03.021_bib0195
  contributor:
    fullname: Paxinos
– volume: 72
  start-page: 1759
  year: 1999
  ident: 10.1016/j.phrs.2016.03.021_bib0025
  article-title: The stimulation of ketogenesis by cannabinoids in cultured astrocytes defines carnitine palmitoyltransferase I as a new ceramide-activated enzyme
  publication-title: J. Neurochem.
  doi: 10.1046/j.1471-4159.1999.721759.x
  contributor:
    fullname: Blázquez
– volume: 153
  start-page: 309
  year: 2008
  ident: 10.1016/j.phrs.2016.03.021_bib0030
  article-title: The peripheral cannabinoid receptor knockout mice: an update
  publication-title: Br. J. Pharmacol.
  doi: 10.1038/sj.bjp.0707527
  contributor:
    fullname: Buckley
– volume: 310
  start-page: 329
  year: 2005
  ident: 10.1016/j.phrs.2016.03.021_bib0270
  article-title: Identification and functional characterization of brainstem cannabinoid CB2 receptors
  publication-title: Science
  doi: 10.1126/science.1115740
  contributor:
    fullname: Van Sickle
– volume: 163
  start-page: 1520
  year: 2011
  ident: 10.1016/j.phrs.2016.03.021_bib0090
  article-title: Cannabinoid receptor agonists modulate oligodendrocyte differentiation by activating PI3K/Akt and the mammalian target of rapamycin (mTOR) pathways
  publication-title: Br. J. Pharmacol.
  doi: 10.1111/j.1476-5381.2011.01414.x
  contributor:
    fullname: Gómez
– volume: 23
  start-page: 11136
  year: 2003
  ident: 10.1016/j.phrs.2016.03.021_bib0020
  article-title: Cannabinoid CB2 receptors and fatty acid amide hydrolase are selectively overexpressed in neuritic plaque-associated glia in Alzheimer's disease brains
  publication-title: J. Neurosci.
  doi: 10.1523/JNEUROSCI.23-35-11136.2003
  contributor:
    fullname: Benito
– volume: 11
  start-page: e3
  year: 2009
  ident: 10.1016/j.phrs.2016.03.021_bib0035
  article-title: Emerging role of the cannabinoid receptor CB2 in immune regulation: therapeutic prospects for neuroinflammation
  publication-title: Expert Rev. Mol. Med.
  doi: 10.1017/S1462399409000957
  contributor:
    fullname: Cabral
– volume: 474
  start-page: 148
  year: 2010
  ident: 10.1016/j.phrs.2016.03.021_bib0185
  article-title: Oleamide suppresses lipopolysaccharide-induced expression of iNOS and COX-2 through inhibition of NF-kappaB activation in BV2 murine microglial cells
  publication-title: Neurosci. Lett.
  doi: 10.1016/j.neulet.2010.03.026
  contributor:
    fullname: Oh
– volume: 52
  start-page: 633
  year: 2013
  ident: 10.1016/j.phrs.2016.03.021_bib0070
  article-title: Cannabinoid receptor signaling in progenitor/stem cell proliferation and differentiation
  publication-title: Prog. Lipid Res.
  doi: 10.1016/j.plipres.2013.05.004
  contributor:
    fullname: Galve-Roperh
– volume: 60
  start-page: 255
  year: 2009
  ident: 10.1016/j.phrs.2016.03.021_bib0005
  article-title: Targeting CB2 receptors and the endocannabinoid system for the treatment of pain
  publication-title: Brain Res. Rev.
  doi: 10.1016/j.brainresrev.2008.12.003
  contributor:
    fullname: Anand
– volume: 293
  start-page: 136
  year: 2000
  ident: 10.1016/j.phrs.2016.03.021_bib0240
  article-title: Effects of cannabinoid receptor agonist and antagonist ligands on production of inflammatory cytokines and anti-inflammatory interleukin-10 in endotoxemic mice
  publication-title: J. Pharmacol. Exp. Ther.
  contributor:
    fullname: Smith
– volume: 35
  start-page: 847
  year: 2013
  ident: 10.1016/j.phrs.2016.03.021_bib0010
  article-title: CB2 cannabinoid receptor agonist ameliorates Alzheimer-like phenotype in AβPP/PS1 mice
  publication-title: J. Alzheimers Dis.
  doi: 10.3233/JAD-130137
  contributor:
    fullname: Aso
– volume: 160
  start-page: 1773
  year: 2010
  ident: 10.1016/j.phrs.2016.03.021_bib0080
  article-title: Depression-resistant endophenotype in mice overexpressing cannabinoid CB2 receptors
  publication-title: Br. J. Pharmacol.
  doi: 10.1111/j.1476-5381.2010.00819.x
  contributor:
    fullname: García-Gutiérrez
– volume: 25
  start-page: 97
  year: 2011
  ident: 10.1016/j.phrs.2016.03.021_bib0130
  article-title: Expression of the mRNA coding the cannabinoid receptor 2 in the pallidal complex of Macaca fascicularis
  publication-title: J. Psychopharmacol.
  doi: 10.1177/0269881110367732
  contributor:
    fullname: Lanciego
– volume: 4
  start-page: e862
  year: 2013
  ident: 10.1016/j.phrs.2016.03.021_bib0265
  article-title: The inhibition of 2-arachidonoyl-glycerol (2-AG) biosynthesis, rather than enhancing striatal damage, protects striatal neurons from malonate-induced death: a potential role of cyclooxygenase-2-dependent metabolism of 2-AG
  publication-title: Cell Death Dis.
  doi: 10.1038/cddis.2013.387
  contributor:
    fullname: Valdeolivas
– volume: 28
  start-page: 39
  year: 2007
  ident: 10.1016/j.phrs.2016.03.021_bib0060
  article-title: Cannabinoid CB2 receptor: a new target for controlling neural cell survival
  publication-title: Trends Pharmacol. Sci.
  doi: 10.1016/j.tips.2006.11.001
  contributor:
    fullname: Fernández-Ruiz
– volume: 58
  start-page: 1913
  year: 2010
  ident: 10.1016/j.phrs.2016.03.021_bib0085
  article-title: The constitutive production of the endocannabinoid 2-arachidonoylglycerol participates in oligodendrocyte differentiation
  publication-title: Glia
  doi: 10.1002/glia.21061
  contributor:
    fullname: Gómez
– volume: 311
  start-page: 253
  year: 2015
  ident: 10.1016/j.phrs.2016.03.021_bib0140
  article-title: Neuronal expression of CB2 cannabinoid receptor mRNAs in the mouse hippocampus
  publication-title: Neuroscience
  doi: 10.1016/j.neuroscience.2015.10.041
  contributor:
    fullname: Li
– volume: 58
  start-page: 1017
  year: 2010
  ident: 10.1016/j.phrs.2016.03.021_bib0250
  article-title: Cannabinoid and cannabinoid-like receptors in microglia, astrocytes, and astrocytomas
  publication-title: Glia
  doi: 10.1002/glia.20983
  contributor:
    fullname: Stella
– volume: 231
  start-page: 1
  year: 2015
  ident: 10.1016/j.phrs.2016.03.021_bib0205
  article-title: Endocannabinoids and their pharmacological actions
  publication-title: Handb. Exp. Pharmacol.
  doi: 10.1007/978-3-319-20825-1_1
  contributor:
    fullname: Pertwee
– volume: 23
  start-page: 1398
  year: 2003
  ident: 10.1016/j.phrs.2016.03.021_bib0275
  article-title: Nonpsychotropic cannabinoid receptors regulate microglial cell migration
  publication-title: J. Neurosci.
  doi: 10.1523/JNEUROSCI.23-04-01398.2003
  contributor:
    fullname: Walter
– volume: 57
  start-page: 1154
  year: 2009
  ident: 10.1016/j.phrs.2016.03.021_bib0225
  article-title: Cannabinoid CB2 receptor agonists protect the striatum against malonate toxicity: relevance for Huntington's disease
  publication-title: Glia
  doi: 10.1002/glia.20838
  contributor:
    fullname: Sagredo
– volume: 62
  start-page: 395
  year: 2014
  ident: 10.1016/j.phrs.2016.03.021_bib0160
  article-title: Validating antibodies to the cannabinoid CB2 receptor: antibody sensitivity is not evidence of antibody specificity
  publication-title: J. Histochem. Cytochem.
  doi: 10.1369/0022155414530995
  contributor:
    fullname: Marchalant
SSID ssj0009410
Score 2.196623
SourceID crossref
SourceType Aggregation Database
StartPage 205
Title Biological characterization of PM226, a chromenoisoxazole, as a selective CB 2 receptor agonist with neuroprotective profile
Volume 110
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELZW5cIF8RRv-YB62c0qcWInPrIBWiG26iFIvUX22gEqdVORLaIrxM_hdzJ-xEm3IFEuUeRYo-zOF3sy-eYbhF7RXIk85jpSDWdRphmNJF3lkYStUycioU5MZ3nEDj9m70_oyWTya8RautjI-Wr7x7qS__EqjIFfTZXsDTwbjMIAnIN_4QgehuM_-dg1knQaH0F4eRuCwOMlMa0VS1MA-dnIEqzbL137XWxbxyEWHVzpbCMcwx8qF1MyhQVQn28Ms_JTa0R1XaLWql56SQcz1Xf6Hke2x4MGtr0hryIUss0H5pP8Ij3T26gU9jxxtWTLeXC6UQvwnQPC4AEYsV_z34ioajtAgk3ufggTjsQ3Szd2lMb5OI2RsECi61deQwOAYKG4sjR7yqtfXGM62qeJKwO9tgW4bMTpHJ4FI8eeMCti68qwr-pt7-yDgZ3YE99Oa2OjNjbqOK1jo1dwi-Scmpf8-c-BSsSzXvXC_QRfnOV4hLv3MQqARpFMdRfd8a8g-LXD0z000ev7aN_773KGq6Ekr5vhfTzy7OUD9GMAHd4FHW4bbEE3wwJfgxwMdjAeAIfLBSa4Bxz2gMMGcHgHcNgD7iGq3r2tysPIt_CIVpwkUZ4pnWY6k40UsFg0hDMer1STF6oxwnJCUq4K0lDOGqJkQlRKZK5kARuDUE2RPkJ763atHyNMuShYnjFCwGKaFoJnihcFSxnTiY7pEzTt_9b63Am11H935NMbzX6Gbg-QfY72Nl8v9AuIRTfypQXCb2u_ih0
link.rule.ids 315,786,790,27957,27958
linkProvider Elsevier
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Biological+characterization+of+PM226%2C+a+chromenoisoxazole%2C+as+a+selective+CB+2+receptor+agonist+with+neuroprotective+profile&rft.jtitle=Pharmacological+research&rft.au=G%C3%B3mez-Ca%C3%B1as%2C+M.&rft.au=Morales%2C+P.&rft.au=Garc%C3%ADa-Toscano%2C+L.&rft.au=Navarrete%2C+C.&rft.date=2016-08-01&rft.issn=1043-6618&rft.volume=110&rft.spage=205&rft.epage=215&rft_id=info:doi/10.1016%2Fj.phrs.2016.03.021&rft.externalDBID=n%2Fa&rft.externalDocID=10_1016_j_phrs_2016_03_021
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1043-6618&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1043-6618&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1043-6618&client=summon